Furthermore, reduced plasma levels of CCL2 were identified in patients with mutations in the GBA gene that encodes the enzyme beta-glucocerebrosidase, in comparison with sporadic Parkinson’s disease patients and controls [36]. The gene discussed is GBA1; the disease is Parkinson disease.